{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:53:14Z","timestamp":1789041194584,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010891","name":"Guizhou Provincial Health Commission","doi-asserted-by":"publisher","award":["gzwkj2025-325"],"award-info":[{"award-number":["gzwkj2025-325"]}],"id":[{"id":"10.13039\/501100010891","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.prp.2026.156450","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T15:53:32Z","timestamp":1774108412000},"page":"156450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["LHX2 is associated with tumor microenvironment characteristics in clear cell renal cell carcinoma and modulates the malignant phenotypes of cancer cells"],"prefix":"10.1016","volume":"282","author":[{"given":"Tengda","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.prp.2026.156450_bib1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal cell carcinoma: a review","volume":"332","author":"Rose","year":"2024","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.prp.2026.156450_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/cancers15030665","article-title":"Clear cell renal cell carcinoma: from biology to treatment","volume":"15","author":"Kase","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2026.156450_bib3","article-title":"Treatment strategies for clear cell renal cell carcinoma: past, present and future","volume":"13","author":"Yang","year":"2023","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156450_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/cells13010034","article-title":"Emerging immunotherapy approaches for advanced clear cell renal cell carcinoma","volume":"13","author":"Meng","year":"2023","journal-title":"Cells"},{"issue":"17","key":"10.1016\/j.prp.2026.156450_bib5","first-page":"576","article-title":"The treatment of metastatic renal cell carcinoma","volume":"121","author":"Ivanyi","year":"2024","journal-title":"Dtsch Arztebl Int"},{"issue":"11","key":"10.1016\/j.prp.2026.156450_bib6","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ccell.2021.10.001","article-title":"Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma","volume":"39","author":"Au","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2026.156450_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1146738","article-title":"The components of tumor microenvironment as biomarker for immunotherapy in metastatic renal cell carcinoma","volume":"14","author":"Su","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.prp.2026.156450_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2018.02.046","article-title":"Lhx2, an evolutionarily conserved, multifunctional regulator of forebrain development","volume":"1705","author":"Chou","year":"2019","journal-title":"Brain Res"},{"issue":"21","key":"10.1016\/j.prp.2026.156450_bib9","doi-asserted-by":"crossref","first-page":"9794","DOI":"10.18632\/aging.102427","article-title":"LHX2 promotes malignancy and inhibits autophagy via mTOR in osteosarcoma and is negatively regulated by miR-129-5p","volume":"11","author":"Song","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10.1016\/j.prp.2026.156450_bib10","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.3892\/ol.2017.6607","article-title":"Inhibition of LHX2 by miR-124 suppresses cellular migration and invasion in non-small cell lung cancer","volume":"14","author":"Yang","year":"2017","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.prp.2026.156450_bib11","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3390\/genes13081457","article-title":"LHX2 enhances the malignant phenotype of esophageal squamous cell carcinoma by upregulating the expression of SERPINE2","volume":"13","author":"Li","year":"2022","journal-title":"Genes (Basel)"},{"issue":"7","key":"10.1016\/j.prp.2026.156450_bib12","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s41416-022-01902-7","article-title":"LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1\/FGFR axis","volume":"127","author":"Xie","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2026.156450_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000521595","article-title":"LIM Homeobox-2 suppresses hallmarks of adult and pediatric liver cancers by inactivating MAPK\/ERK and Wnt\/Beta-Catenin Pathways","volume":"11","author":"Mosca","year":"2021","journal-title":"Liver Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156450_bib14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s12967-024-05238-z","article-title":"Integrative analyses of bulk and single-cell transcriptomics reveals the infiltration and crosstalk of cancer-associated fibroblasts as a novel predictor for prognosis and microenvironment remodeling in intrahepatic cholangiocarcinoma","volume":"22","author":"Zhong","year":"2024","journal-title":"J. Transl. Med"},{"issue":"10","key":"10.1016\/j.prp.2026.156450_bib15","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.3390\/cancers15102773","article-title":"LHX2 is a potential biomarker and associated with immune infiltration in breast cancer","volume":"15","author":"Zhang","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1A","key":"10.1016\/j.prp.2026.156450_bib16","article-title":"The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Conte Oncol. (Pozn. )"},{"issue":"Database","key":"10.1016\/j.prp.2026.156450_bib17","first-page":"D991","article-title":"NCBI GEO: archive for functional genomics data sets--update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.prp.2026.156450_bib18","doi-asserted-by":"crossref","first-page":"D711","DOI":"10.1093\/nar\/gky964","article-title":"ArrayExpress update - from bulk to single-cell expression data","volume":"47","author":"Athar","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"10.1016\/j.prp.2026.156450_bib19","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.prp.2026.156450_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinforma."},{"issue":"1","key":"10.1016\/j.prp.2026.156450_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac558","article-title":"GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels","volume":"24","author":"Liu","year":"2023","journal-title":"Brief. Bioinform"},{"key":"10.1016\/j.prp.2026.156450_bib22","doi-asserted-by":"crossref","unstructured":"Harrell F.E. Jr. rms: Regression Modeling Strategies. 2015.","DOI":"10.1007\/978-3-319-19425-7"},{"issue":"6","key":"10.1016\/j.prp.2026.156450_bib23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis. Mak."},{"issue":"7","key":"10.1016\/j.prp.2026.156450_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.prp.2026.156450_bib25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"6","key":"10.1016\/j.prp.2026.156450_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.prp.2026.156450_bib27","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.prp.2026.156450_bib28","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2026.156450_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-0716-0327-7_17","article-title":"EPIC: a tool to estimate the proportions of different cell types from bulk gene expression data","volume":"2120","author":"Racle","year":"2020","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156450_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156450_bib31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol."},{"issue":"10","key":"10.1016\/j.prp.2026.156450_bib32","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med"},{"issue":"W1","key":"10.1016\/j.prp.2026.156450_bib33","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"7391","key":"10.1016\/j.prp.2026.156450_bib34","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature11005","article-title":"Systematic identification of genomic markers of drug sensitivity in cancer cells","volume":"483","author":"Garnett","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.prp.2026.156450_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12859-020-03947-y","article-title":"Predicting chemosensitivity using drug perturbed gene dynamics","volume":"22","author":"Mannheimer","year":"2021","journal-title":"BMC Bioinforma."},{"issue":"7873","key":"10.1016\/j.prp.2026.156450_bib36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.prp.2026.156450_bib37","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.prp.2026.156450_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Chemin.."},{"issue":"16","key":"10.1016\/j.prp.2026.156450_bib39","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.prp.2026.156450_bib40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.prp.2026.156450_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.745412","article-title":"An Active Fraction of Trillium tschonoskii Promotes the Regeneration of Intestinal Epithelial Cells After Irradiation","volume":"9","author":"Song","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.prp.2026.156450_bib42","doi-asserted-by":"crossref","first-page":"8490","DOI":"10.1080\/21655979.2022.2051805","article-title":"Epigallocatechin-3-gallate suppresses the growth of human osteosarcoma by inhibiting the Wnt\/\u03b2-catenin signalling pathway","volume":"13","author":"Dong","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.prp.2026.156450_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9557859","article-title":"Long noncoding RNA TUG1 inhibits tumor progression through regulating Siglec-15-related anti-immune activity in hepatocellular carcinoma","volume":"2022","author":"Ren","year":"2022","journal-title":"J. Immunol. Res"},{"issue":"1","key":"10.1016\/j.prp.2026.156450_bib44","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12872-022-02621-w","article-title":"H3K9me2 regulation of BDNF expression via G9a partakes in the progression of heart failure","volume":"22","author":"Yan","year":"2022","journal-title":"BMC Cardiovasc Disord."},{"key":"10.1016\/j.prp.2026.156450_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6119737","article-title":"Identification of 20(S)-Ginsenoside Rh2 as a Potential EGFR Tyrosine Kinase Inhibitor","volume":"2022","author":"Liang","year":"2022","journal-title":"Oxid. Med Cell Longev."},{"issue":"D1","key":"10.1016\/j.prp.2026.156450_bib46","doi-asserted-by":"crossref","first-page":"D184","DOI":"10.1093\/nar\/gkaf1209","article-title":"JASPAR 2026: expansion of transcription factor binding profiles and integration of deep learning models","volume":"54","author":"Ovek Baydar","year":"2026","journal-title":"Nucleic Acids Res"},{"issue":"32","key":"10.1016\/j.prp.2026.156450_bib47","doi-asserted-by":"crossref","first-page":"19425","DOI":"10.1073\/pnas.2003913117","article-title":"Kr\u00fcppel-like factor 17 upregulates uterine corin expression and promotes spiral artery remodeling in pregnancy","volume":"117","author":"Wang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"16","key":"10.1016\/j.prp.2026.156450_bib48","doi-asserted-by":"crossref","first-page":"9246","DOI":"10.1093\/nar\/gkab679","article-title":"Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma","volume":"49","author":"Huang","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.prp.2026.156450_bib49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12943-023-01824-9","article-title":"Extracellular vesicle-circEHD2 promotes the progression of renal cell carcinoma by activating cancer-associated fibroblasts","volume":"22","author":"He","year":"2023","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2026.156450_bib50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","article-title":"Clear cell renal cell carcinoma ontogeny and mechanisms of lethality","volume":"17","author":"Jonasch","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"issue":"9","key":"10.1016\/j.prp.2026.156450_bib51","doi-asserted-by":"crossref","first-page":"7946","DOI":"10.3390\/ijms24097946","article-title":"The tumor immune microenvironment in clear cell renal cell carcinoma","volume":"24","author":"Monjaras-Avila","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.prp.2026.156450_bib52","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41581-025-00983-w","article-title":"Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors","volume":"21","author":"Burgers","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"issue":"17","key":"10.1016\/j.prp.2026.156450_bib53","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.3390\/cancers14174072","article-title":"The extracellular matrix environment of clear cell renal cell carcinoma","volume":"14","author":"Oxburgh","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"23","key":"10.1016\/j.prp.2026.156450_bib54","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.3390\/cancers13235873","article-title":"The extracellular matrix environment of clear cell renal cell carcinoma determines cancer associated fibroblast growth","volume":"13","author":"Bond","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2026.156450_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110888","article-title":"Comprehensive analysis of subtypes and risk model based on complement system associated genes in ccRCC","volume":"111","author":"Li","year":"2023","journal-title":"Cell Signal"},{"key":"10.1016\/j.prp.2026.156450_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1023177","article-title":"The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2026.156450_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.686907","article-title":"Development and validation of an IL6\/JAK\/STAT3-related gene signature to predict overall survival in clear cell renal cell carcinoma","volume":"9","author":"Zhan","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156450_bib58","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s10238-024-01414-z","article-title":"ISG15 promotes tumor progression via IL6\/JAK2\/STAT3 signaling pathway in ccRCC","volume":"24","author":"Xie","year":"2024","journal-title":"Clin. Exp. Med"},{"key":"10.1016\/j.prp.2026.156450_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1276658","article-title":"The utilization of single-cell sequencing technology in investigating the immune microenvironment of ccRCC","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol."},{"issue":"22","key":"10.1016\/j.prp.2026.156450_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70212","article-title":"Exploring the immune landscape of ccRCC: prognostic signatures and therapeutic implications","volume":"28","author":"Pan","year":"2024","journal-title":"J. Cell Mol. Med"},{"issue":"1","key":"10.1016\/j.prp.2026.156450_bib61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13046-023-02742-w","article-title":"TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma","volume":"42","author":"Xu","year":"2023","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.prp.2026.156450_bib62","article-title":"Cancer-associated fibroblasts in clear cell renal cell carcinoma: functional heterogeneity, tumor microenvironment crosstalk, and therapeutic opportunities","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.prp.2026.156450_bib63","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/bju.15506","article-title":"Cancer-associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti-angiogenic therapy","volume":"129","author":"Ambrosetti","year":"2022","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.prp.2026.156450_bib64","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s13402-025-01079-0","article-title":"OTUD1 downregulates PD-L1 expression by deubiquitinating STAT3 and promotes the immune response in ccRCC","volume":"48","author":"Liang","year":"2025","journal-title":"Cell Oncol (Dordr)"},{"issue":"12","key":"10.1016\/j.prp.2026.156450_bib65","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.3390\/biomedicines10123244","article-title":"Role of nivolumab in the modulation of PD-1 and PD-L1 expression in papillary and clear cell renal carcinoma (RCC)","volume":"10","author":"Bialek","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2026.156450_bib66","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s12935-020-01603-2","article-title":"CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC)","volume":"20","author":"Liu","year":"2020","journal-title":"Cancer Cell Int"},{"issue":"9","key":"10.1016\/j.prp.2026.156450_bib67","doi-asserted-by":"crossref","first-page":"7755","DOI":"10.3390\/ijms24097755","article-title":"ARHGAP11A is a novel prognostic and predictive biomarker correlated with immunosuppressive microenvironment in clear cell renal cell carcinoma","volume":"24","author":"Yang","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156450_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1485580","article-title":"Lactylation-related gene signature accurately predicts prognosis and immunotherapy response in gastric cancer","volume":"14","author":"Sun","year":"2024","journal-title":"Front Oncol."},{"issue":"5","key":"10.1016\/j.prp.2026.156450_bib69","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/bjc.2016.230","article-title":"Medical treatment of renal cancer: new horizons","volume":"115","author":"Greef","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.prp.2026.156450_bib70","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.21037\/tcr-23-2247","article-title":"Adjuvant therapy in renal cell carcinoma (RCC): progress, at last","volume":"13","author":"Bueno","year":"2024","journal-title":"Transl. Cancer Res"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:39:59Z","timestamp":1785508799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826001019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":70,"alternative-id":["S0344033826001019"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156450","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LHX2 is associated with tumor microenvironment characteristics in clear cell renal cell carcinoma and modulates the malignant phenotypes of cancer cells","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156450"}}